Risk of Parkinson's disease among first-degree relatives: A community- based study

Neurology

Volumn 47, Issue 1, 1996, Pages 155-160

  Marder, K ^a,b,c   Tang, M X ^a,b,c   Mejia, H ^b   Alfaro, B ^b   Cote L ^b,c   Louis, E ^a,b,c   Groves, J ^b   Mayeux, R ^a,b,c,d  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Columbia University ^*  (United States)

^c Sergievsky Center ^*  (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAUCASIAN; ENVIRONMENTAL FACTOR; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT; RISK FACTOR;

EID: 0030056696     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.1.155     Document Type: Article

References (27)

1. Waters CH, Miller CA. Autosomal dominant Lewy body parkinsonism in a four-generation family. Ann Neurol 1994;35: 59-64.
2. Wszolek ZK, Pfeiffer B, Fulgham JE, et al. Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 1995;45:502-505.
3. Golbe LI, Lazzarini AM, Schwarz KO, Mark MH, Dickson DW, Duvoisin RC. Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology. Neurology 1993;43:2222-2227.
4. Golbe LI, Di Iorio G, Bonavita V, Miller D, Duvoisin R. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 1990;27:276-282.
5. Spellman G. Report of familial cases of parkinsonism; evidence of a dominant trait in patient's family. JAMA 1962;179: 372-374.
6. Muenter MD, Howard FM, Okazaki H. A familial Parkinson-dementia syndrome [abstract]. Neurology 1986;36(suppl 1): 115.
7. Barbeau A, Roy M, Paris S, Cloutier T, Plasse L, Poirier J. Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet 1985;2:1213-1216.
8. Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992;339:1017-1018.
9. Smith CA, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-1377.
10. Duvoisin R, Gearing F, Schweitzer M, Yahr M. A family study of parkinsonism. In: Barbeau A, Brunette JR, eds. Progress in neurogenetics. Amsterdam: Excerpta Medica, 1969:492-496.
11. Marttila RJ, Rinne UK. Arteriosclerosis, heredity, and some previous infections in the etiology of Parkinson's disease. A case-control study. Clin Neurol Neurosurg 1976;71:46-56.
12. Lazzarini AM, Myers RH, Zimmerman Jr TR, et al. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 1994;44:499-506.
13. Payami H, Larsen K, Bernard S, Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 1994;36:659-661.
14. Payami H, Bernard S, Larsen K, Kaye J, Nutt J. Genetic anticipation in Parkinson's disease. Neurology 1995;45:135-138.
15. Mayeux R, Marder K, Cote L, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in Northern Manhattan, 1988-1993. Am J Epidemiol 1995;142: 820-827.
16. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. In: Streiffler MB, Korczyn AD, Melamed E, Youdim MB, eds. Parkinson's disease: anatomy, pathology and therapy. New York: Raven Press, 1990:245-249.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55:181-184.
18. Hughes AJ, Ben-Schlomo Y, Daniel SE, Lees AJ. What fea tures improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42:1142-1146.
19. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 1992; 49:492-497.
20. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 1992; 49:453-460.
21. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley & Sons, 1981:218.
22. Tang M-X, Tsai W-Y, Marder K, Mayeux R. Linear rank tests for doubly censored data. Stat Med 1995;14:2555-2563.
23. Schoenberg BS, Osuntokun BO, Adeuja AOG, et al. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 1988;38:645-646.
24. Mjones H. Paralysis agitans: a clinical and genetic study. Acta Psychiatr Neurol 1949;54:1-195.
25. Semchuk KM, Love EJ, Lee RG. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 1993;43: 1173-1180.
26. Breteler MMB, Tzourio C, Manubens-Bertran J-M, Lopez-Pousa S, Rocca WA, Alperwitch A. Risk factors for Parkinson's disease: a population-based case-control study (Europarkinson) [abstract]. Neurology 1995;45(suppl 4):A214.
27. Purdy A, Hahn A, Barnett HJ. Familial fatal parkinsonism with alveolar hypoventilation and mental depression. Ann Neurol 1979;6:523-531.